Excelsior Biopharma Inc. develops and sells pharmaceutical products in Taiwan, China, and internationally. It offers general pharmaceuticals; orphan drugs; antidotes; rapid test kits and reagent; consumer products under the Repavar, Om3gafort, Oral7, and Excelsior Probiotics brand names; and over the counter drugs under the Norit, Puresenna, and Tazac brand names. The company also provides specialty medicine and public health products. In addition, it is involved in importing and exporting of active pharmaceutical ingredients, food, and cosmeceuticals; development of cosmetics; research, importing and exporting of technologies; and pharmaceutical technologies transfer. The company was formerly known as Excelsior Enterprise Co., Ltd. and changed its name to Excelsior Biopharma Inc. in June 2003. Excelsior Biopharma Inc. was founded in 1986 and is headquartered in Taipei, Taiwan.
Frequently asked questions
What sector does Excelsior Biopharma (6496) operate in?
Excelsior Biopharma belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Excelsior Biopharma (6496) current stock price?
As of the latest data, Excelsior Biopharma stock price is NT$24.30, with a previous close of NT$24.20. Excelsior Biopharma gained NT$0.10 in the last trading session, representing a 0.41% increase.
What is Excelsior Biopharma (6496) current market capitalization?
Excelsior Biopharma market cap is approximately 1.13 billion.
What is Excelsior Biopharma (6496) Earnings Per Share (EPS)?
The trailing EPS is -NT$4.26.
Does Excelsior Biopharma (6496) pay dividends?
No. Excelsior Biopharma does not pay a dividend.
What is Excelsior Biopharma (6496) beta (volatility) score?
Excelsior Biopharma has a beta of -0.168, indicating lower volatility than the overall market.
